Documents

THERAPEUTICS AND CLINICAL RISK MANAGEMENT II

SPECIAL ISSUE IN SPANISH. SUPPLEMENT I 2007

A new treatment alternative in rhinosinusitis using plant extracts

Therapeutics and clinical risk management 2007 in PDF

Index of articles:

Dr. Perotti, his experience with Nasodren

This content is restricted. To read the interview, please enter your password.
If you still don't have one, please fill our form.

International experience

Observational experience in post-traumatic


Contraindications


Handling and storage


Practical aspects

This content is restricted. To read the interview, please enter your password.
If you still don't have one, please fill our form.

Hartington Pharma owns Nasodren® for sinusitis treatment